Treating Relapsed/Refractory Acute Myeloid Leukemia with Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor with Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Wen Yao; Xinchen Fang; Peng Jiang; Juan Tong; Liangquan Geng; Xiaoyu Zhu; Baolin Tang; Xiang Wan; Kaidi Song; Lei Zhang; Ping Qiang; Guangyu Sun; Yongsheng Han; Huilan Liu; Zimin Sun

doi:10.4084/MJHID.2022.025

Treating Relapsed/Refractory Acute Myeloid Leukemia with Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor with Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Mediterr J Hematol Infect Dis. 2022 Mar 1;14(1):e2022025. doi: 10.4084/MJHID.2022.025. eCollection 2022.

Authors

Wen Yao¹, Xinchen Fang², Peng Jiang³, Juan Tong¹, Liangquan Geng¹, Xiaoyu Zhu¹, Baolin Tang¹, Xiang Wan¹, Kaidi Song¹, Lei Zhang¹, Ping Qiang¹, Guangyu Sun¹, Yongsheng Han¹, Huilan Liu¹, Zimin Sun¹

Affiliations

¹ Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Sciences and Technology of China, Hefei, Anhui 230001, P. R. China.
² Central Laboratory of Medical Research Centre, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P. R. China.
³ Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230031, P. R. China.

No abstract available

Keywords: Allogeneic hematopoietic stem cell transplantation; Chidamide; Cytarabine; Fludarabine; Granulocyte colony-stimulating factor; Relapsed/refractory acute myeloid leukemia; Survival.